Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Whitehawk Therapeutics
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026
May 22, 2026
Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series
May 22, 2026
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026
May 21, 2026
Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
May 17, 2026
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
May 16, 2026
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016
January 8, 2026
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer
December 1, 2025
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 27, 2025
Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
November 14, 2025
Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC
October 25, 2025